Lupin gets USFDA approval for generic version of Cyanocobalamin nasal spray ...Middle East

Business Standard - Economy
Lupin gets USFDA approval for generic version of Cyanocobalamin nasal spray
Pharma major Lupin Ltd on Monday said it has received approval from the US health regulator for its generic version of Cyanocobalamin nasal spray. The approval granted by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Cyanocobalamin nasal spray of strength 500 mcg/spray (one spray per device), Lupin said in a statement. Cyanocobalamin nasal spray is used to maintain normal vitamin B12 blood levels in patients with pernicious anaemia. "This product will be manufactured at Lupin's Somerset facility in the US," the company added. Cyanocobalamin nasal spray had estimated annual sales of USD 69 million in the US, Lupin said, citing IQVIA MAT March 2023

Hence then, the article about lupin gets usfda approval for generic version of cyanocobalamin nasal spray was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin gets USFDA approval for generic version of Cyanocobalamin nasal spray )

Apple Storegoogle play

Last updated :

Also on site :



Latest News